These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8485892)

  • 1. Growing use of nonisotopic CA 19-9 immunoassays increases between-laboratory variability.
    Zucchelli GC; Pilo A; Chiesa MR; Cohen R; Bizollon CA
    Clin Chem; 1993 May; 39(5):909-11. PubMed ID: 8485892
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.
    Pilo A; Zucchelli GC; Cohen R; Bizollon CA; Cappelli G; Cianetti A; Gion M; Piffanelli A; Bombardieri E
    Tumori; 1995; 81(2):117-24. PubMed ID: 7539965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant serum CA 125 values in commercial immunoassays.
    van Kamp GJ; Verstraeten AA; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an immunoradiometric and an immunoluminometric assay for the evaluation of the tumour associated antigens CA 19-9 and CA 125.
    Mader RM; Steger GG; Braun J; Rainer H
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):85-90. PubMed ID: 8003582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial results by CA 125 immunoradiometric assay and enzyme-linked immunosorbent assay not due to human anti-murine antibody.
    Mustafa G; Bieglmayer C; Pohl A; Kölbl H; Gabl F
    Clin Chem; 1992 Oct; 38(10):2157-9. PubMed ID: 1395017
    [No Abstract]   [Full Text] [Related]  

  • 6. "High-dose hook effect" with the Centocor CA 125 assay.
    Pesce MA
    Clin Chem; 1993 Jun; 39(6):1347. PubMed ID: 8504549
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.
    Kenemans P; van Kamp GJ; Oehr P; Verstraeten RA
    Clin Chem; 1993 Dec; 39(12):2509-13. PubMed ID: 8252723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of CA 19.9, CA 125 and CA 15.3 assays as observed through an external quality assessment program.
    Zucchelli GC; Pilo A; Chiesa MR; Masini S; Clerico A
    Int J Biol Markers; 1994; 9(1):43-7. PubMed ID: 8051434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-mouse antibodies against OC-125 do not interfere in a CA-125 assay that uses OC-125 and M11 antibodies.
    Jäger W; Zoller O
    Clin Chem; 1993 Jul; 39(7):1556-7. PubMed ID: 8330426
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoluminometric assay for determining CA 72-4 in patients with gynecological tumors.
    Heinze T; Greiner-Mai E
    Clin Chem; 1996 Mar; 42(3):472-4. PubMed ID: 8598120
    [No Abstract]   [Full Text] [Related]  

  • 12. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic and clinical studies on ELSA CA 72-4 kit for measurement of serum CA 72-4 concentrations: usefulness in patients with gastrointestinal cancer].
    Nakai T; Endo K; Nakajima K; Hattori N; Hosono M; Saga T; Watanabe Y; Sakahara H; Konishi J; Tobe T
    Kaku Igaku; 1990 May; 27(5):505-11. PubMed ID: 2395235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the T.A.T.I. marker with CEA and Ca 19-9 in neoplasms of the gastrointestinal system. Preliminary data].
    Ricci E; Pecchio F; Rapellino M; Giaccone M; Adamo R; Boltri F; Oliaro A
    Minerva Dietol Gastroenterol; 1988; 34(4):217-20. PubMed ID: 3247053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
    Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers.
    Kokociñska D; Jarzab B; Król R; Ziaja K; Szejbak K; Kuśmierski S
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):283-7. PubMed ID: 9216823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CA 125 in benign and malignant pathology of the female genital tract and neoplasms of the gastrointestinal tract].
    Debiasi D; Gramellini D; Montagna S; Calbiani B; Franchini D; Capocasale E; Capelli P; Casoni P
    Minerva Ginecol; 1988 Mar; 40(3):153-7. PubMed ID: 3173763
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of serum SC6 antigen using immunoradiometric assay for diagnosis of pancreatic cancer].
    Guo XZ; Liu MP; Li XX
    Zhonghua Nei Ke Za Zhi; 1992 Feb; 31(2):84-6, 125. PubMed ID: 1395920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.